Drug
Kava
Kava is a pharmaceutical drug with 5 clinical trials. Currently 1 active trials ongoing. Historical success rate of 50.0%.
Total Trials
5
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
50.0%
Based on 1 completed trials
Completion Rate
50%(1/2)
Active Trials
1(20%)
Results Posted
0%(0 trials)
Terminated
1(20%)
Phase Distribution
Ph phase_1
1
20%
Ph phase_2
2
40%
Ph not_applicable
1
20%
Ph early_phase_1
1
20%
Phase Distribution
2
Early Stage
2
Mid Stage
0
Late Stage
Phase Distribution5 total trials
Early Phase 1First-in-human
1(20.0%)
Phase 1Safety & dosage
1(20.0%)
Phase 2Efficacy & side effects
2(40.0%)
N/ANon-phased studies
1(20.0%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
33.3%
1 of 3 finished
Non-Completion Rate
66.7%
2 ended early
Currently Active
1
trials recruiting
Total Trials
5
all time
Status Distribution
Active(1)
Completed(1)
Terminated(2)
Other(1)
Detailed Status
Suspended1
Completed1
Withdrawn1
Terminated1
Active, not recruiting1
Development Timeline
Analytics
Development Status
Total Trials
5
Active
1
Success Rate
50.0%
Most Advanced
Phase 2
Trials by Phase
Early Phase 11 (20.0%)
Phase 11 (20.0%)
Phase 22 (40.0%)
N/A1 (20.0%)
Trials by Status
suspended120%
completed120%
withdrawn120%
terminated120%
active_not_recruiting120%
Recent Activity
1 active trials
Showing 5 of 5
active_not_recruitingphase_2
Reducing Tobacco-associated Lung Cancer Risk: A Randomized Clinical Trial of AB-free Kava
NCT05081882
suspendedearly_phase_1
Effect of Kava on Anxiety and Stress in Cancer Survivors
NCT06213298
withdrawnphase_1
Exploring the Impact of Two-week Kava on the Metabolism of Nicotine and NNK
NCT03606655
completednot_applicable
Investigation of Kava Effects on NNK Metabolism
NCT02500472
terminatedphase_2
Kava Kava for the Treatment of Generalized Anxiety Disorder (GAD)
NCT00083980
Clinical Trials (5)
Showing 5 of 5 trials
NCT05081882Phase 2
Reducing Tobacco-associated Lung Cancer Risk: A Randomized Clinical Trial of AB-free Kava
NCT06213298Early Phase 1
Effect of Kava on Anxiety and Stress in Cancer Survivors
NCT03606655Phase 1
Exploring the Impact of Two-week Kava on the Metabolism of Nicotine and NNK
NCT02500472Not Applicable
Investigation of Kava Effects on NNK Metabolism
NCT00083980Phase 2
Kava Kava for the Treatment of Generalized Anxiety Disorder (GAD)
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5